Cargando…

A novel plant‐made monoclonal antibody enhances the synergetic potency of an antibody cocktail against the SARS‐CoV‐2 Omicron variant

This study describes a novel, neutralizing monoclonal antibody (mAb), 11D7, discovered by mouse immunization and hybridoma generation, against the parental Wuhan‐Hu‐1 RBD of SARS‐CoV‐2. We further developed this mAb into a chimeric human IgG and recombinantly expressed it in plants to produce a mAb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jugler, Collin, Sun, Haiyan, Nguyen, Katherine, Palt, Roman, Felder, Mitchell, Steinkellner, Herta, Chen, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946148/ https://www.ncbi.nlm.nih.gov/pubmed/36403203 http://dx.doi.org/10.1111/pbi.13970

Ejemplares similares

The potency and synergy of plant‐made monoclonal antibodies against the BA.5 variant of SARS‐CoV‐2
por: Sun, Haiyan, et al.
Publicado: (2023)

Potential for a Plant-Made SARS-CoV-2 Neutralizing Monoclonal Antibody as a Synergetic Cocktail Component
por: Jugler, Collin, et al.
Publicado: (2022)

A Monoclonal Antibody Produced in Glycoengineered Plants Potently Neutralizes Monkeypox Virus
por: Esqueda, Adrian, et al.
Publicado: (2023)

A Dual-Approach Strategy to Optimize the Safety and Efficacy of Anti-Zika Virus Monoclonal Antibody Therapeutics
por: Sun, Haiyan, et al.
Publicado: (2023)

SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody
por: Jugler, Collin, et al.
Publicado: (2021)

Plant-Produced Anti-Zika Virus Monoclonal Antibody Glycovariant Exhibits Abrogated Antibody-Dependent Enhancement of Infection
por: Yang, Ming, et al.
Publicado: (2023)

Highly active engineered IgG3 antibodies against SARS-CoV-2
por: Kallolimath, Somanath, et al.
Publicado: (2021)

Humanization and expression of IgG and IgM antibodies in plants as potential diagnostic reagents for Valley Fever
por: Jugler, Collin, et al.
Publicado: (2022)

Hydrophobin-Protein A Fusion Protein Produced in Plants Efficiently Purified an Anti-West Nile Virus Monoclonal Antibody from Plant Extracts via Aqueous Two-Phase Separation
por: Jugler, Collin, et al.
Publicado: (2020)

In vitro and in vivo efficacy of anti‐chikungunya virus monoclonal antibodies produced in wild‐type and glycoengineered Nicotiana benthamiana plants
por: Hurtado, Jonathan, et al.
Publicado: (2019)

Influence of Cocktails of Labeled Monoclonal Antibodies on the Localization of Antibodies in Human Tumor Xenografts
por: Watanabe, Yuji, et al.
Publicado: (1990)

Rapid High Yield Production of Different Glycoforms of Ebola Virus Monoclonal Antibody
por: Castilho, Alexandra, et al.
Publicado: (2011)

A Humanized Monoclonal Antibody Cocktail to Prevent Pulmonary Ricin Intoxication
por: Rong, Yinghui, et al.
Publicado: (2020)

Antiviral monoclonal antibody cocktails as a modern weapon in combating pandemics
por: Liu, Dingjiang, et al.
Publicado: (2021)

Omicron variant evolution on vaccines and monoclonal antibodies
por: Sabbatucci, Michela, et al.
Publicado: (2023)

Epitope-directed monoclonal antibody production using a mixed antigen cocktail facilitates antibody characterization and validation
por: Liew, Oi Wah, et al.
Publicado: (2021)

Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG
por: Sun, Lin, et al.
Publicado: (2021)

Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
por: Yang, Yang, et al.
Publicado: (2022)

AFIR: A Dimensionless Potency Metric for Characterizing the Activity of Monoclonal Antibodies
por: Stein, AM, et al.
Publicado: (2017)

Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans
por: Müller, Thomas, et al.
Publicado: (2009)

Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome Coronavirus
por: Sivapalasingam, Sumathi, et al.
Publicado: (2021)

A broad-spectrum and highly potent human monoclonal antibody cocktail for rabies prophylaxis
por: Kim, Pan Kyeom, et al.
Publicado: (2021)

Engineering SARS-CoV-2 cocktail antibodies into a bispecific format improves neutralizing potency and breadth
por: Ku, Zhiqiang, et al.
Publicado: (2022)

Omicron sublineage BQ.1.1 resistance to monoclonal antibodies
por: Arora, Prerna, et al.
Publicado: (2023)

Clinical Laboratory Utility of a Humanized Antibody in Commercially Available Enzyme Immunoassays for Coccidioidomycosis
por: Grill, Francisca J., et al.
Publicado: (2022)

Glyco engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues
por: Kallolimath, Somanath, et al.
Publicado: (2023)

Tyrosine O-sulfation proteoforms affect HIV-1 monoclonal antibody potency
por: Cai, Cindy X., et al.
Publicado: (2022)

Correction: Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans
por: Müller, Thomas, et al.
Publicado: (2009)

Epitope Dampening Monotypic Measles Virus Hemagglutinin Glycoprotein Results in Resistance to Cocktail of Monoclonal Antibodies
por: Lech, Patrycja J., et al.
Publicado: (2013)

SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies
por: Chao, Tzu-Yuan, et al.
Publicado: (2017)

Molecular Characterization of the Monoclonal Antibodies Composing ZMAb: A Protective Cocktail Against Ebola Virus
por: Audet, Jonathan, et al.
Publicado: (2014)

Author Correction: Epitope-directed monoclonal antibody production using a mixed antigen cocktail facilitates antibody characterization and validation
por: Liew, Oi Wah, et al.
Publicado: (2021)

Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth
por: Ku, Zhiqiang, et al.
Publicado: (2022)

The Trophic Cocktail Made by Chromaffin Cells
por: Unsicker, K., et al.
Publicado: (1992)

Epitope mapping and a cocktail of monoclonal antibodies to achieve full detection coverage of potato virus Y
por: Zhao, Cui‐Ling, et al.
Publicado: (2023)

Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors: Fc-mediated avidity enhances the potency of an anti-TLR4 antibody
por: Loyau, Jérémy, et al.
Publicado: (2014)

Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
por: Chavarot, Nathalie, et al.
Publicado: (2022)

In-Silico Analysis of Monoclonal Antibodies against SARS-CoV-2 Omicron
por: Hu, Ye-Fan, et al.
Publicado: (2022)

Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariants
por: Desautels, Thomas A., et al.
Publicado: (2023)

Improving the efficacy of plant-made anti-HIV monoclonal antibodies for clinical use
por: Grandits, Melanie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j8sbe5bokabe5fkbg1vdi2cgfl